3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Tumor-Agnostic
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Breast
1
Conditions
Neoplasms
1
Interventions
pembrolizumab
12
Specimen Handling
8
Biopsy
8
Magnetic Resonance Spectroscopy
7
Paclitaxel
6
trastuzumab deruxtecan
4
Fluorouracil
4
Bevacizumab
4
durvalumab
3
Pemetrexed
3
Oxaliplatin
3
Leucovorin
3
Exercise
3
Cetuximab
3
Carboplatin
3
Capecitabine
3
Blood Specimen Collection
3
trametinib
2
olaparib
2
nilotinib
2
dostarlimab
2
cabozantinib
2
X-Rays
2
Temozolomide
2
Standard of Care
2
Radiosurgery
2
Nivolumab
2
Irinotecan
2
Cisplatin
2
zolbetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Navigation
×
Tumor-Agnostic
×
30 days
×
Clear all
NCT04234646
2026-06-02
Patient Navigation 2.0
Northwestern University
Phase NA
Completed
600 enrolled